NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: SCHOTT North America
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SCHOTT Introduces TOPPAC® Cosmetic Syringes - International technology group SCHOTT is introducing SCHOTT TOPPAC® cosmetic, a new COC (cyclic olefin copolymer) polymer syringe specifically designed for cosmetic and medical applications involving hyaluronic acid - SCHOTT.com
SCHOTT Introduces TOPPAC® Cosmetic Syringes

 

NewswireToday - /newswire/ - Elmsford, NY, United States, 2019/02/01 - International technology group SCHOTT is introducing SCHOTT TOPPAC® cosmetic, a new COC (cyclic olefin copolymer) polymer syringe specifically designed for cosmetic and medical applications involving hyaluronic acid - SCHOTT.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thanks to a reduced needle pop-off risk, improved dose accuracy and high break resistance, the syringes are especially suitable for highly viscous drugs. The new polymer syringes will become available in February 2019 and will be displayed at IMCAS World Congress in Paris, Jan. 31 to Feb. 2, at TSK Laboratory’s booth #46.

Highly viscous formulations require the user to apply a great amount of force when injecting the gel, leading to discomfort or pain for the patient. In extreme cases, the applied strength can even result in needle pop-off, when the needle hub is disconnected from the syringe.

To ensure a safe and easy administration, SCHOTT TOPPAC® cosmetic syringes feature an integrated luer lock for a secure needle attachment and are compatible with most of the common needles on the market. A study conducted by SCHOTT found that the combination of the new syringe and the STERiJECT needle with HPC hub from TSK Laboratory, a leading manufacturer of needles for dermal fillers, showed superior results with an improved injection performance. Moreover, thanks to a reduced inner diameter of the barrel, the syringe system enables optimized extrusion forces and an improved dose accuracy. As part of the complete syringe system offering, the syringes are equipped with ergonomic container components to further simplify and relieve the injection process. The new syringes, which are made of COC, an advanced cyclic olefin copolymer of the highest purity, come with a 1ml filling volume in a ready-to-use format and are manufactured in fully integrated clean rooms equipped with state-of-the-art production technology.

“The highly viscous hyaluronic acid falls into the category of dermal fillers and is used to restore facial volume,” explains Tom van Ginneken, Global Product Manager SCHOTT TOPPAC® syringes. “Hence, the new syringes were primarily developed for the cosmetic market, which has recently seen a double digit growth rate”. The market growth is also reflected in the company’s investment in its polymer container production at its sites in Müllheim, Germany, and in St. Gallen, Switzerland.

Enhanced knowledge
SCHOTT has extensive expertise in manufacturing pharmaceutical packaging made out of polymer and this know-how was taken to develop the new SCHOTT TOPPAC® cosmetic syringes. The new syringes are part of the company’s broad portfolio of polymer and glass pharmaceutical containers, with SCHOTT TOPPAC® polymer syringes being commercially available in more than 90 countries.

SCHOTT (schott.com) is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. With more than 15,500 employees at production sites and sales offices in 34 countries, the group has a global presence. In the 2017/2018 fiscal year, SCHOTT generated sales of 2.08 billion euros. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. This is one of the oldest private and one of the largest science-promoting foundations in Germany. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: SCHOTT North America

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


SCHOTT Introduces TOPPAC® Cosmetic Syringes

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Rina DellaVecchia - SCHOTT North America, Inc. 
914-831-2286 public.relations[.]us.schott.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SCHOTT North America securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From SCHOTT North America / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Announces Acquisition of Inscopix for Neuroscience Research
hemotune Applauded by Frost & Sullivan for Enabling Selective and Efficient Extraction of Large Compounds from Blood with its Purification Platform
MediView Medical Monitor and New 23.8' MediClient Variant Complement Kontron's Medical Technology Portfolio
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
Top Artificial Intelligence Trends Influencing the Future of Radiology According to Frost & Sullivan
Clarius Applauded by Frost & Sullivan with 2022 North American Portable Ultrasound Technology Innovation Leadership Award
PeriGen Applauded by Frost & Sullivan for Its Innovative Perinatal Software Solutions for Fetal Monitoring and Clinical Decision Support
Institut Curie and Thales Team to Create World-leading French Industrial Ecosystem in Very High-energy Electron FLASH Radiotherapy
Bruker Introduces Novel NMR Probe Technology for Biological Research
Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with its Revolutionary Implant RefluxStop™
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
Smart Glove Lauded by Frost & Sullivan for Leading the Global Medical Gloves Industry with Pioneering Products and Creative Innovations
LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with its Interoperable Precision Health So
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow, Inc.





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)